A615 (Permax 0.05 MG)

Generic Name: pergolide

Pill imprint A615 has been identified as Permax 0.05 MG.

Permax is used in the treatment of parkinson's disease; tourette's syndrome; hyperprolactinemia and belongs to the drug class dopaminergic antiparkinsonism agents. There is no proven risk in humans during pregnancy. Permax 0.05 MG is not a controlled substance under the Controlled Substance Act (CSA).

Permax

Generic Name:

pergolide

Imprint:

A615

Strength:

0.05 MG

Color:

Yellow

Shape:

Rectangle

Availability:

Prescription only

Drug Class:

Dopaminergic antiparkinsonism agents

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Athena

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.